Tenax Therapeutics, Inc. (TENX) is a publicly traded Healthcare sector company. As of May 21, 2026, TENX trades at $12.00 with a market cap of $308.22M and a P/E ratio of -8.85. TENX moved +4.49% today. Year to date, TENX is -2.60%; over the trailing twelve months it is +100.00%. Its 52-week range spans $3.25 to $18.38. Analyst consensus is strong buy with an average price target of $31.50. Rallies surfaces TENX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Who is trading TENX stock inside the company?
Recent TENX insider activity includes Rich Stuart bought 2.50K, Rich Stuart bought 2.50K, Rich Stuart bought 2.50K, Rich Stuart bought 1.50K, and Rich Stuart bought 1.00K. Rallies tracks insider transaction dates, shares, prices, and estimated values.
TENX Key Metrics
Key financial metrics for TENX
Metric
Value
Price
$12.00
Market Cap
$308.22M
P/E Ratio
-8.85
EPS
$-1.34
Dividend Yield
0.00%
52-Week High
$18.38
52-Week Low
$3.25
Volume
0
Avg Volume
0
Revenue (TTM)
$0
Net Income
$-52.60M
Gross Margin
0.00%
Recent TENX Insider Trades
Rich Stuart bought 2.50K (~$25.54K) on Dec 9, 2025.
Rich Stuart bought 2.50K (~$25.25K) on Dec 8, 2025.
Rich Stuart bought 2.50K (~$23.00K) on Dec 4, 2025.
Rich Stuart bought 1.50K (~$13.62K) on Dec 3, 2025.
Rich Stuart bought 1.00K (~$9.01K) on Dec 2, 2025.
Recent TENX insider activity includes Rich Stuart bought 2.50K, Rich Stuart bought 2.50K, Rich Stuart bought 2.50K, Rich Stuart bought 1.50K, and Rich Stuart bought 1.00K. Rallies tracks insider transaction dates, shares, prices, and estimated values.
Does Rallies show Form 4 insider transactions for TENX?
Yes. Rallies tracks TENX insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.
Is TENX research on Rallies investment advice?
No. Rallies provides research, data, and educational context for TENX. It does not provide personalized investment advice.
